Axonics Modulation Technologies Inc (AXNX)

Add to Watchlists
Create an Alert
20.42 +0.09  +0.44% NASDAQ Oct 17, 17:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
12/11/2019 16:30 EST Misc Axonics Modulation Technologies Inc Third Quarter Earnings Conference Call in 2019
12/11/2019 Earnings Axonics Modulation Technologies Inc Third Quarter Earnings in 2019 Release
08/19/2019 12:00 EDT Misc Axonics Modulation Technologies Inc Annual General Meeting in 2018
08/05/2019 16:30 EDT Misc Axonics Modulation Technologies Inc Second Quarter Earnings Conference Call in 2019
08/05/2019 Earnings Axonics Modulation Technologies Inc Second Quarter Earnings in 2019 Release
05/08/2019 16:30 EDT Misc Axonics Modulation Technologies Inc First Quarter Earnings Conference Call in 2019
05/08/2019 Earnings Axonics Modulation Technologies Inc First Quarter Earnings in 2019 Release
03/05/2019 16:30 EST Misc Axonics Modulation Technologies Inc Fourth Quarter Earnings Conference Call in 2018
03/05/2019 Earnings Axonics Modulation Technologies Inc Fourth Quarter Earnings in 2018 Release
03/05/2019 Misc Axonics Modulation Technologies Inc Annual Report in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.axonicsmodulation.com
  • Investor Relations URL: N/A
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Medical Devices
  • Equity Style: N/A
  • Next Earnings Release: Dec. 11, 2019
  • Last Earnings Release: Aug. 05, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Axonics Modulation Technologies Inc is a United stated based medical technology company. It focuses on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (SNM) solutions. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention. The company has designed and developed the r-SNM System, which delivers mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of overactive bladder and fecal incontinence.

Top Fund Holders

Symbol Name Weighting
HHCCX Highland Long/Short Healthcare C 1.87%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.